Pharmaceuticals Overview: Drugs Not Affected by PBS Price Changes
Monday, 9 February 2026, 11:15
Pharmaceuticals and PBS Pricing Changes
Pharmaceuticals are at the forefront of healthcare advancements, yet not all medications benefit from recent price adjustments under the Pharmaceutical Benefits Scheme (PBS). Painkillers, HRT therapies, and incontinence medicines are among the medications whose prices will remain unchanged at over $25, despite the initiative aimed at making drugs more affordable.
Impact on Patients
- Patients requiring incontinence treatments may experience continued financial strain.
- Heart disease drugs face similar challenges in accessibility due to the pricing structure.
- Blood thinners remain crucial for many patients, but their affordability is not addressed by the PBS changes.
Overall, while the PBS aims to provide relief on specific pharmaceuticals, several vital therapies will not see a reduction in costs.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.